United States Cellular Crecimiento futuro
Future controles de criterios 3/6
Se prevé un crecimiento anual de los beneficios y los ingresos de United States Cellular de 21.3% y 0.4% por año respectivamente. Se prevé que el BPA crezca en un 21.2% al año. Se espera que la rentabilidad financiera sea de 2.6% en 3 años.
Información clave
21.3%
Tasa de crecimiento de los beneficios
21.2%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Wireless Telecom | 14.0% |
Tasa de crecimiento de los ingresos | 0.4% |
Rentabilidad financiera futura | 2.6% |
Cobertura de analistas | Good |
Última actualización | 17 Apr 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
United States Cellular Corporation's (NYSE:USM) Earnings Haven't Escaped The Attention Of Investors
Apr 17Is United States Cellular (NYSE:USM) Using Too Much Debt?
Mar 19There Are Reasons To Feel Uneasy About United States Cellular's (NYSE:USM) Returns On Capital
Jan 30Getting In Cheap On United States Cellular Corporation (NYSE:USM) Is Unlikely
Jan 09United States Cellular (NYSE:USM) Use Of Debt Could Be Considered Risky
Dec 19United States Cellular Is Priced Above Likely Sale Value
Dec 16An Intrinsic Calculation For United States Cellular Corporation (NYSE:USM) Suggests It's 44% Undervalued
Nov 28United States Cellular Q3: Decent Quarter But Stock Is Way Ahead
Nov 07United States Cellular (NYSE:USM) Might Be Having Difficulty Using Its Capital Effectively
Oct 12Does United States Cellular (NYSE:USM) Have A Healthy Balance Sheet?
Sep 11U.S. Cellular: Valuing In Light Of A Potential Acquisition
Aug 22United States Cellular (NYSE:USM) Could Be Struggling To Allocate Capital
Jul 14United States Cellular: Things Can Get Even Worse
Jun 01Is United States Cellular (NYSE:USM) A Risky Investment?
May 19Slowing Rates Of Return At United States Cellular (NYSE:USM) Leave Little Room For Excitement
Mar 26United States Cellular: 5G Commercialization Risks Remain, But Cheap
Feb 23United States Cellular GAAP EPS of -$0.33 misses by $0.01, revenue of $1.05B misses by $30M
Feb 16Does United States Cellular (NYSE:USM) Have A Healthy Balance Sheet?
Jan 31United States Cellular's (NYSE:USM) Returns On Capital Are Heading Higher
Dec 20Is United States Cellular (NYSE:USM) A Risky Investment?
Oct 17U.S. Cellular taps Williams for board seat
Oct 17United States Cellular (NYSE:USM) Is Looking To Continue Growing Its Returns On Capital
Sep 05United States Cellular (NYSE:USM) Use Of Debt Could Be Considered Risky
Jul 09United States Cellular Corporation (NYSE:USM) Shares Could Be 37% Below Their Intrinsic Value Estimate
Jun 20United States Cellular (NYSE:USM) Is Experiencing Growth In Returns On Capital
May 11Is United States Cellular (NYSE:USM) Using Too Much Debt?
Mar 28United States Cellular (NYSE:USM) Might Have The Makings Of A Multi-Bagger
Jan 31Does United States Cellular (NYSE:USM) Have A Healthy Balance Sheet?
Dec 17We Like These Underlying Return On Capital Trends At United States Cellular (NYSE:USM)
Nov 01United States Cellular: Approaching A Long-Term Buying Opportunity
Sep 22Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 3,897 | 132 | N/A | N/A | 3 |
12/31/2025 | 3,827 | 80 | 649 | 1,199 | 8 |
12/31/2024 | 3,836 | 76 | 791 | 1,465 | 7 |
12/31/2023 | 3,906 | 54 | 128 | 866 | N/A |
9/30/2023 | 3,955 | 12 | 218 | 899 | N/A |
6/30/2023 | 4,074 | -23 | -50 | 644 | N/A |
3/31/2023 | 4,145 | -6 | -115 | 562 | N/A |
12/31/2022 | 4,169 | 30 | -355 | 832 | N/A |
9/30/2022 | 4,189 | 85 | -504 | 787 | N/A |
6/30/2022 | 4,122 | 131 | -341 | 1,017 | N/A |
3/31/2022 | 4,109 | 144 | -379 | 989 | N/A |
12/31/2021 | 4,122 | 155 | -1,244 | 802 | N/A |
9/30/2021 | 4,126 | 133 | -1,116 | 954 | N/A |
6/30/2021 | 4,137 | 185 | -1,191 | 908 | N/A |
3/31/2021 | 4,097 | 218 | -1,219 | 1,019 | N/A |
12/31/2020 | 4,037 | 229 | 47 | 1,237 | N/A |
9/30/2020 | 4,016 | 242 | -97 | 987 | N/A |
6/30/2020 | 4,020 | 180 | -75 | 940 | N/A |
3/31/2020 | 4,019 | 144 | -240 | 779 | N/A |
12/31/2019 | 4,022 | 127 | -197 | 724 | N/A |
9/30/2019 | 4,021 | 130 | -141 | 796 | N/A |
6/30/2019 | 3,991 | 143 | -62 | 820 | N/A |
3/31/2019 | 3,991 | 159 | 122 | 808 | N/A |
12/31/2018 | 3,967 | 150 | 187 | 709 | N/A |
9/30/2018 | 3,944 | 402 | 183 | 675 | N/A |
6/30/2018 | 3,906 | 67 | 129 | 614 | N/A |
3/31/2018 | 3,896 | 31 | -44 | 596 | N/A |
12/31/2017 | 3,890 | 12 | -185 | 469 | N/A |
9/30/2017 | 3,867 | -266 | N/A | 480 | N/A |
6/30/2017 | 3,927 | 50 | N/A | 460 | N/A |
3/31/2017 | 3,957 | 65 | N/A | 399 | N/A |
12/31/2016 | 3,990 | 48 | N/A | 501 | N/A |
9/30/2016 | 3,972 | 51 | N/A | 415 | N/A |
6/30/2016 | 4,018 | 98 | N/A | 393 | N/A |
3/31/2016 | 4,001 | 90 | N/A | 463 | N/A |
12/31/2015 | 4,031 | 241 | N/A | 555 | N/A |
9/30/2015 | 4,019 | 222 | N/A | 397 | N/A |
6/30/2015 | 3,950 | 135 | N/A | 382 | N/A |
3/31/2015 | 3,932 | 98 | N/A | 364 | N/A |
12/31/2014 | 3,893 | -43 | N/A | 172 | N/A |
9/30/2014 | 3,787 | -20 | N/A | 325 | N/A |
6/30/2014 | 3,726 | -8 | N/A | 55 | N/A |
3/31/2014 | 3,763 | 155 | N/A | 131 | N/A |
12/31/2013 | 3,919 | 140 | N/A | 291 | N/A |
9/30/2013 | 4,131 | 99 | N/A | 587 | N/A |
6/30/2013 | 4,332 | 144 | N/A | 936 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (21.3% al año) de USM es superior a la tasa de ahorro (2.3%).
Beneficios vs. Mercado: Se prevé que los beneficios (21.3% al año) de USM crezcan más rápidamente que el mercado US (14.7% al año).
Beneficios de alto crecimiento: Se espera que los beneficios de USM crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (0.4% al año) de USM crezcan más despacio que el mercado de US (8.1% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 0.4% al año) de USM crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de USM sea baja dentro de 3 años (2.6%).